William Blair Initiates Coverage On Cytokinetics with Outperform Rating
William Blair analyst Alethia Young initiates coverage on Cytokinetics (NASDAQ:CYTK) with a Outperform rating.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga